OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Relevance of Biochemical Deep Phenotyping for a Personalised Approach to Parkinson’s Disease
Claudio Giuliano, Silvia Cerri, Valentina Cesaroni, et al.
Neuroscience (2022) Vol. 511, pp. 100-109
Closed Access | Times Cited: 5
Claudio Giuliano, Silvia Cerri, Valentina Cesaroni, et al.
Neuroscience (2022) Vol. 511, pp. 100-109
Closed Access | Times Cited: 5
Showing 5 citing articles:
New Pieces for an Old Puzzle: Approaching Parkinson’s Disease from Translatable Animal Models, Gut Microbiota Modulation, and Lipidomics
Lorena Ortega Moreno, Ana Bagüés, Vicente Martı́nez, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2775-2775
Open Access | Times Cited: 10
Lorena Ortega Moreno, Ana Bagüés, Vicente Martı́nez, et al.
Nutrients (2023) Vol. 15, Iss. 12, pp. 2775-2775
Open Access | Times Cited: 10
Bibliometric Analysis of Alpha‐Synuclein Determination by Biopsy in Peripheral Tissues of Patients With Parkinson’s Disease
Aigerim B. Utegenova, Aigul P. Yermagambetova, Gulnar B Kabdrakhmanova, et al.
International Journal of Telemedicine and Applications (2025) Vol. 2025, Iss. 1
Open Access
Aigerim B. Utegenova, Aigul P. Yermagambetova, Gulnar B Kabdrakhmanova, et al.
International Journal of Telemedicine and Applications (2025) Vol. 2025, Iss. 1
Open Access
Modulation of Alpha-Synuclein Conformational Ensemble and Aggregation Pathways by Dopamine and Related Molecules
Antonino Natalello, Stefania Brocca, Erika Ponzini, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 2
Antonino Natalello, Stefania Brocca, Erika Ponzini, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 10
Open Access | Times Cited: 2
Novel C-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson’s Disease
Ram W. Sabnis, Anika R. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 698-699
Open Access | Times Cited: 1
Ram W. Sabnis, Anika R. Sabnis
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 698-699
Open Access | Times Cited: 1
An update on the pharmacogenetic considerations when prescribing dopamine receptor agonists for Parkinson’s disease
Pedro Ayuso, Félix Javier Jiménez‐Jiménez, Javier Gómez‐Tabales, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 7, pp. 447-460
Closed Access
Pedro Ayuso, Félix Javier Jiménez‐Jiménez, Javier Gómez‐Tabales, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 7, pp. 447-460
Closed Access
